Other genetic risk loci particularly associated with the development of anti-citrullinated peptide antibody (ACPA)-positive RA, include genes that influence T cell function and the handling of arthritogenic antigens [11-13]. The gene discussed is PRTN3; the disease is rheumatoid arthritis.